Heparin Sodium; Taurolidine Patent Expiration
Heparin Sodium; Taurolidine is used for preventing catheter-related bloodstream infections in hemodialysis patients. It was first introduced by Cormedix Inc
Heparin Sodium; Taurolidine Patents
Given below is the list of patents protecting Heparin Sodium; Taurolidine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Defencath | US11738120 | Synthesis of taurolidine, purity profiles and polymorphs | Apr 15, 2042 | Cormedix |
| Defencath | US7696182 | Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin | May 16, 2025 | Cormedix |
| Defencath | US8541393 | Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin | Nov 02, 2024 | Cormedix |
| Defencath | US9339036 | Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin | Nov 02, 2024 | Cormedix |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳